← Back to Screener
Aspire Biopharma Holdings, Inc. Warrant (ASBPW)
Price$0.02
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-7.93%
Price vs S&P 500 (4W)15.47%
VGM Score46.15
All Metrics
Price vs S&P 500 (YTD)28.80%
10-Day Avg Trading Volume0.05M
3-Month Avg Trading Volume0.03M
52-Week High$0.09
26-Week Price Return0.00%
13-Week Price Return12.00%
3-Month Return Std Dev197.87%
Year-to-Date Return35.76%
5-Day Price Return57.75%
Month-to-Date Return60.00%
Price vs S&P 500 (13W)3.75%
Beta-1.47x
52-Week Low$0.01
mGradeC
vgmGradeC
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ASBPWAspire Biopharma Holdings, Inc. Warrant | — | — | C | $0.02 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Aspire Biopharma Holdings Inc develops nanotechnology-based drug delivery systems designed to administer pain and inflammation medications while bypassing the gastrointestinal tract. The company's proprietary formulation platform aims to provide alternatives to traditional oral medications, including opioid-based therapies. Its technology is intended to improve therapeutic outcomes and reduce medication-related risks.